Jiangsu Lanfeng Bio-chemical Co.,Ltd

Shenzhen Stock Exchange 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd Revenue Per Share for the year ending December 31, 2023: USD 0.66

Jiangsu Lanfeng Bio-chemical Co.,Ltd Revenue Per Share is USD 0.66 for the year ending December 31, 2023, a 6.83% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Jiangsu Lanfeng Bio-chemical Co.,Ltd Revenue Per Share for the year ending December 31, 2022 was USD 0.62, a -7.84% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd Revenue Per Share for the year ending December 31, 2021 was USD 0.67, a 10.53% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd Revenue Per Share for the year ending December 31, 2020 was USD 0.60, a -4.84% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd Revenue Per Share for the year ending December 31, 2019 was USD 0.64, a 0.30% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shenzhen Stock Exchange: 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd

CEO	Mr. Jun Xing
IPO Date	Dec. 3, 2010
Location	China
Headquarters	No. 1 Suhua Road
Employees	1,573
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The company is based in Xinyi, China.

Key trends

Past 5 years